[balsam]

Speaking as an quantum computing academic, I would suggest that money should be redirected from quantum computing into all kinds of biotech, except quantum computing based biotech. There’s never too little money invested in biotech research (as clinical as you can manage), only too much money off siphoned by lab reagent and equipment manufacturers. Unfortunately, non-biotech VCs have even less understanding of this tech than even quantum. That is, assuming most physicists “don’t even understand quantum” — hey, that is why I am a physicist, not a VC. But might considering becoming one after I sell my billion dollar bootstrapped QC company. Yep! The first QC giant will not take —or need—outside funding, for bloody obvious reasons. Just as the first hegemonic semitech company (Intel) birthed Venture Capital (and just like CAS hegemon Wolfram birthed a new kind of science /s) the first hegemonic qtech company will birth a new funding model (/s?)